Lyme Disease Diagnostics Market Size, Share, and Analysis, By Diagnostic Technology (Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and others), By Sample (Blood, Cerebrospinal Fluid, Joint Fluid, Urine), By End User (Hospitals, Public/Private Laboratories and Physicians Office) and Regional Forecasts, 2022-2032
Lyme Disease Diagnostics Market Size, Share, and Analysis, By Diagnostic Technology (Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and others), By Sample (Blood, Cerebrospinal Fluid, Joint Fluid, Urine), By End User (Hospitals, Public/Private Laboratories and Physicians Office) and Regional Forecasts, 2022-2032
PRODUCT OVERVIEW:
Lyme disease is occurred due t%li%a bacterial infection by borrelia species. This is spread through the bite of infected ticks in humans. The symptoms of Lyme disease in infected patients are fever, skin rashes, depression & fatigue. Early detection of the disease may be treated with antibiotics. By prolonging the disease without treating it, results in heart, joint and CNS disorders and might become fatal. The diagnostics intended t%li%trat the lyme disease are called Lyme disease diagnostics.
MARKET HIGHLIGHTS
Global Lyme Disease Diagnostics Market is expected t%li%project a CAGR of 6.8% during the forecast period, 2022-2032
Global Lyme Disease Diagnostics Market is expected t%li%reach USD 3.7 billion, growing at a CAGR of 6.8% during forecast period. Increasing focus of governments towards well establishment of healthcare facilities, growing prevalence of Lyme disease and the emergence of new Lyme disease diagnostic tests are expected t%li%drive the growth of the Global Lyme Disease Diagnostics market. Rising enthusiasm of key players towards Research & Development of Lyme disease diagnosis is expected t%li%drive the growth of the market.
GLOBAL LYME DISEASE DIAGNOSTICS MARKET SEGMENTATION:
Serological Test Segment is expected t%li%grow with high CAGR during the forecast period
Global Lyme Disease Diagnostics Market is classified based on the Diagnostic Technology int%li%Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and Others. Serological test segment is expected t%li%dominate the market in the forecast period owing t%li%the preference of this test t%li%measures the antibodies in the later phase of illness after nucleic acid test and PCR test which are advantageous in assessing Lyme disease.
Hospital Segment is expected t%li%grow with high CAGR during the forecast period
Global Lyme Disease Diagnostics Market is classified based on the End User int%li%Hospitals, Public/Private Laboratories, and Physicians Office. Hospital segment is expected t%li%dominate the Lyme disease diagnostic market in the forecast period owing t%li%the growing hospitals count with skilled professionals, availability of commercial diagnostic kits t%li%identify Lyme disease easily and well-structured healthcare infrastructure which is expected t%li%boost the market growth.
MARKET DYNAMICS:
Growth Drivers
Increasing Patient Population is Expected t%li%Boost the Growth of the Market
Introduction of New Initiatives by the Government is Expected t%li%Boost the Growth of the Market
Restraint
Lack of Disease Awareness May Hamper the Market Growth
GLOBAL LYME DISEASE DIAGNOSTICS MARKET
Key Players Covered:
Global Lyme Disease Diagnostics Market is segmented based on regional analysis int%li%five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominated the Lyme disease diagnostics market in 2021 and is expected t%li%dominate the same over the forecast period owing t%li%the increasing government initiatives for diagnosing and treating of several diseases. The focus t%li%develop new strategies in order t%li%prevent Lyme disease has increased aiming t%li%reduce occurrence of disease in population. The increment in pervasiveness of common tick disease, resulted in creating demand for disease treatment, thereby resulting in driving the growth of Lyme Disease Diagnostics Market.
PRODUCT OVERVIEW:
Lyme disease is occurred due t%li%a bacterial infection by borrelia species. This is spread through the bite of infected ticks in humans. The symptoms of Lyme disease in infected patients are fever, skin rashes, depression & fatigue. Early detection of the disease may be treated with antibiotics. By prolonging the disease without treating it, results in heart, joint and CNS disorders and might become fatal. The diagnostics intended t%li%trat the lyme disease are called Lyme disease diagnostics.
MARKET HIGHLIGHTS
Global Lyme Disease Diagnostics Market is expected t%li%project a CAGR of 6.8% during the forecast period, 2022-2032
Global Lyme Disease Diagnostics Market is expected t%li%reach USD 3.7 billion, growing at a CAGR of 6.8% during forecast period. Increasing focus of governments towards well establishment of healthcare facilities, growing prevalence of Lyme disease and the emergence of new Lyme disease diagnostic tests are expected t%li%drive the growth of the Global Lyme Disease Diagnostics market. Rising enthusiasm of key players towards Research & Development of Lyme disease diagnosis is expected t%li%drive the growth of the market.
GLOBAL LYME DISEASE DIAGNOSTICS MARKET SEGMENTATION:
Serological Test Segment is expected t%li%grow with high CAGR during the forecast period
Global Lyme Disease Diagnostics Market is classified based on the Diagnostic Technology int%li%Serological Test (ELISA, Western Blot), Lymphocytic Transformation Test, Urine Antigen Testing, Immunofluorescent Staining, Nucleic acid Test and Others. Serological test segment is expected t%li%dominate the market in the forecast period owing t%li%the preference of this test t%li%measures the antibodies in the later phase of illness after nucleic acid test and PCR test which are advantageous in assessing Lyme disease.
Hospital Segment is expected t%li%grow with high CAGR during the forecast period
Global Lyme Disease Diagnostics Market is classified based on the End User int%li%Hospitals, Public/Private Laboratories, and Physicians Office. Hospital segment is expected t%li%dominate the Lyme disease diagnostic market in the forecast period owing t%li%the growing hospitals count with skilled professionals, availability of commercial diagnostic kits t%li%identify Lyme disease easily and well-structured healthcare infrastructure which is expected t%li%boost the market growth.
MARKET DYNAMICS:
Growth Drivers
Increasing Patient Population is Expected t%li%Boost the Growth of the Market
Introduction of New Initiatives by the Government is Expected t%li%Boost the Growth of the Market
Restraint
Lack of Disease Awareness May Hamper the Market Growth
GLOBAL LYME DISEASE DIAGNOSTICS MARKET
Key Players Covered:
- Bio-Rad Laboratories, Inc.
- Abbott
- Therm%li%Fisher Scientific, Inc.
- Oxford Immunotec Global PLC
- T2 Biosystems, Inc.
- Quidel Corporation
- Hoffmann-La Roche Ltd
- Graphene Frontiers
- Diasorin S.p.A
- Trinity Biotech
- Quest Diagnostics
- Other Prominent Player
Global Lyme Disease Diagnostics Market is segmented based on regional analysis int%li%five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominated the Lyme disease diagnostics market in 2021 and is expected t%li%dominate the same over the forecast period owing t%li%the increasing government initiatives for diagnosing and treating of several diseases. The focus t%li%develop new strategies in order t%li%prevent Lyme disease has increased aiming t%li%reduce occurrence of disease in population. The increment in pervasiveness of common tick disease, resulted in creating demand for disease treatment, thereby resulting in driving the growth of Lyme Disease Diagnostics Market.
- Reasons t%li%Purchase this Report
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight int%li%the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1. Regional Market Share
1.2. Business Trends
1.3. Lyme Disease Diagnostics Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Lyme Disease Diagnostics Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 LYME DISEASE DIAGNOSTICS MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 LYME DISEASE DIAGNOSTICS MARKET
10.1. Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Diagnostic Technology
11.3.1.1. Serological Test (ELISA, Western Blot)
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Lymphocytic Transformation Test
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Urine Antigen Testing
11.3.1.3.1. By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4. Immunofluorescent Staining
11.3.1.4.1. By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5. Nucleic acid Test
11.3.1.5.1. By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6. Others
11.3.1.6.1. By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Sample
11.3.2.1. Blood
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Cerebrospinal Fluid
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Joint Fluid
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2. Market Share (%) 2022-2032F
11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.4. Urine
11.3.2.4.1. By Value (USD Million) 2022-2032F
11.3.2.4.2. Market Share (%) 2022-2032F
11.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.3. By End User
11.3.3.1. Hospitals
11.3.3.1.1. By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Public/Private Laboratories
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2. Market Share (%) 2022-2032F
11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Physician’s Office
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2. Market Share (%) 2022-2032F
11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
12 NORTH AMERICA LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Diagnostic Technology
12.3.2. By Sample
12.3.3. By End User
12.4. Country
12.4.1. United States
12.4.2. Canada
13 EUROPE LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Diagnostic Technology
13.3.2. By Sample
13.3.3. By End User
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Diagnostic Technology
14.3.2. By Sample
14.3.3. By End User
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Diagnostic Technology
15.3.2. By Sample
15.3.3. By End User
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Diagnostic Technology
16.3.2. By Sample
16.3.3. By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. Bio-Rad Laboratories, Inc.
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Abbott
18.3. Thermo Fisher Scientific, Inc.
18.4. Oxford Immunotec Global PLC
18.5. T2 Biosystems, Inc.
18.6. Quidel Corporation
18.7. Hoffmann-La Roche Ltd
18.8. Graphene Frontiers
18.9. Diasorin S.p.A
18.10. Trinity Biotech
18.11. Quest Diagnostics
18.12. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
1.1. Regional Market Share
1.2. Business Trends
1.3. Lyme Disease Diagnostics Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Lyme Disease Diagnostics Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 LYME DISEASE DIAGNOSTICS MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 LYME DISEASE DIAGNOSTICS MARKET
10.1. Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Diagnostic Technology
11.3.1.1. Serological Test (ELISA, Western Blot)
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Lymphocytic Transformation Test
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Urine Antigen Testing
11.3.1.3.1. By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4. Immunofluorescent Staining
11.3.1.4.1. By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5. Nucleic acid Test
11.3.1.5.1. By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.6. Others
11.3.1.6.1. By Value (USD Million) 2022-2032F
11.3.1.6.2. Market Share (%) 2022-2032F
11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Sample
11.3.2.1. Blood
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Cerebrospinal Fluid
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Joint Fluid
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2. Market Share (%) 2022-2032F
11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.4. Urine
11.3.2.4.1. By Value (USD Million) 2022-2032F
11.3.2.4.2. Market Share (%) 2022-2032F
11.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.3. By End User
11.3.3.1. Hospitals
11.3.3.1.1. By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Public/Private Laboratories
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2. Market Share (%) 2022-2032F
11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Physician’s Office
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2. Market Share (%) 2022-2032F
11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
12 NORTH AMERICA LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Diagnostic Technology
12.3.2. By Sample
12.3.3. By End User
12.4. Country
12.4.1. United States
12.4.2. Canada
13 EUROPE LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Diagnostic Technology
13.3.2. By Sample
13.3.3. By End User
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Diagnostic Technology
14.3.2. By Sample
14.3.3. By End User
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Diagnostic Technology
15.3.2. By Sample
15.3.3. By End User
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA LYME DISEASE DIAGNOSTICS MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Diagnostic Technology
16.3.2. By Sample
16.3.3. By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. Bio-Rad Laboratories, Inc.
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Abbott
18.3. Thermo Fisher Scientific, Inc.
18.4. Oxford Immunotec Global PLC
18.5. T2 Biosystems, Inc.
18.6. Quidel Corporation
18.7. Hoffmann-La Roche Ltd
18.8. Graphene Frontiers
18.9. Diasorin S.p.A
18.10. Trinity Biotech
18.11. Quest Diagnostics
18.12. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
